Begin typing your search above and press return to search.
Herd Immunity Cannot Be A Strategic Choice: Government
By: Tupaki Desk | 31 July 2020 4:37 AM GMT
With the rising coronavirus, from commoner to VIPs are eagerly looking for a vaccine which can put an end to the virus. Globally, there have been over 1.72 crores confirmed cases of COVID-19. More than 6.69 lakh people have died so far.
Meanwhile, Rajesh Bhushan, the officer on special duty, health ministry, on Thursday said that herd immunity cannot be a strategic choice or option for a country of India's size as this would come at a huge cost in terms of lakhs of infected people and many deaths.
The official also said following social norms till a vaccine comes is the only viable option. He added that the government has not signed an agreement with any vaccine manufacturing company yet.
"There are multiple stakeholders within and outside government and ministry of health has started actively engaging with such stakeholders. It's too premature to comment on supply and distribution of vaccine at this stage but whenever it comes it has to be deployed on a much larger scale than the existing vaccines," said Bhushan.
Meanwhile, Rajesh Bhushan, the officer on special duty, health ministry, on Thursday said that herd immunity cannot be a strategic choice or option for a country of India's size as this would come at a huge cost in terms of lakhs of infected people and many deaths.
The official also said following social norms till a vaccine comes is the only viable option. He added that the government has not signed an agreement with any vaccine manufacturing company yet.
"There are multiple stakeholders within and outside government and ministry of health has started actively engaging with such stakeholders. It's too premature to comment on supply and distribution of vaccine at this stage but whenever it comes it has to be deployed on a much larger scale than the existing vaccines," said Bhushan.
